HomeALM • BME
Almirall SA
€9.51
Jan 31, 10:03:00 PM GMT+1 · EUR · BME · Disclaimer
StockES listed security
Previous close
€9.51
Day range
€9.35 - €9.59
Year range
€7.85 - €10.04
Market cap
2.03B EUR
Avg Volume
113.00K
P/E ratio
-
Dividend yield
1.93%
Primary exchange
BME
CDP Climate Change Score
A-
In the news
Financials
Income Statement
Revenue
Net income
(EUR)Sep 2024Y/Y change
Revenue
231.12M10.44%
Operating expense
90.74M7.23%
Net income
-8.19M-616.72%
Net profit margin
-3.54-565.79%
Earnings per share
EBITDA
45.19M-11.73%
Effective tax rate
-389.83%
Total assets
Total liabilities
(EUR)Sep 2024Y/Y change
Cash and short-term investments
343.10M37.29%
Total assets
2.31B-1.92%
Total liabilities
839.20M2.30%
Total equity
1.47B
Shares outstanding
213.47M
Price to book
1.38
Return on assets
0.23%
Return on capital
0.29%
Net change in cash
(EUR)Sep 2024Y/Y change
Net income
-8.19M-616.72%
Cash from operations
39.79M667.72%
Cash from investing
34.32M165.79%
Cash from financing
-10.36M-29.76%
Net change in cash
63.75M194.91%
Free cash flow
125.43M222.79%
About
Almirall, S.A. is a Spanish pharmaceutical company dedicated to medical dermatology, with headquarters in Barcelona, founded in 1944. In 2023, the company generated total revenues of €898.8 million and was the leading European company in medical dermatology. With approximately 1,904 employees, it has a direct presence in 20 countries through its 15 subsidiaries in Europe and the USA. Wikipedia
Founded
1944
Employees
1,996
Search
Clear search
Close search
Google apps
Main menu